Multiple Paths Can Lead to Cybersecurity Success 
Instruct3D Strengthens Additive Build Intelligence Message Following ICAM 2026 
Otto Group and Sereact Bring NVIDIA-Powered Physical AI to Returns Processing BioSyent Announces Renewal of Normal Course Issuer Bid
MISSISSAUGA, Ontario, Dec. 13, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
Humacyte Hosting Key Opinion Leader Webinar on Vascular Trauma: Ukrainian Surgeons Discuss Use of Human Acellular Vessels™ (HAV™) in Wartime
Thursday, December 15, 2022 @ 8:00 AM ET DURHAM, N.C., Dec. 13, 2022 (GLOBE NEWSWIRE)…
Fate Therapeutics Features Multiple Novel Approaches to Eliminate Conditioning Chemotherapy for Off-the-shelf, iPSC-derived Cell Therapies at 2022 ASH Annual Meeting
Next-generation Engineering Strategies Designed to Resist Host Immune Cell Rejection Show Enhanced Functionality and Persistence…
Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin’s Potential for Treating Fungal Keratitis
Additionally, Brilacidin to be Screened by NIH/NIAID to Further Characterize Its Broad-Spectrum Antifungal Activity WAKEFIELD,…
Arbutus Completes Enrollment in its Phase 2a Clinical Trial Combining AB-729 with NA Therapy and Peginterferon alfa-2a in Patients with Chronic Hepatitis B Virus Infection
Preliminary data from lead-in phase further validates AB-729’s capacity to reduce HBsAg Initial data from…
Syneos Health Extends Partnership with Medable
Continued Collaboration Will Accelerate Bringing Clinical Trials Closer to the Patient MORRISVILLE, N.C., Dec. 13,…
OpGen Announces Positive Top Line Data from Clinical Trial for Unyvero Urinary Tract Infection Panel
Study has enrolled over 1,800 patient samples at 4 U.S. clinical trial sites Primary endpoint…
Cellectis Announces Positive Preliminary Clinical Data for UCART22 in ALL and UCART123 in AML
Cellectis’ Pipeline Overview Cellectis’ Fully Owned & Licensed Product Candidate Pipeline UCART22: anti-tumor activity observed…
Cellectis Announces Positive Preliminary Clinical Data for UCART22 in ALL and UCART123 in AML
Cellectis’ Pipeline Overview Cellectis’ Fully Owned & Licensed Product Candidate Pipeline UCART22: anti-tumor activity observed…
Spectral Medical Announces Strategic Joint Venture With Infomed to Accelerate Commercialization of Dimi and Sami Dialysis Devices
Spectral to receive a significant equity stake in the joint venture, while eliminating its need…
Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets
Wave receives upfront payment of $170 million in cash and equity, also eligible to receive…
OmicsVeu Launches An Extensive Line Of Spatial Biology Products For Multiplex Multi-omics
Fremont, Dec. 13, 2022 (GLOBE NEWSWIRE) — OmicsVeu, a wholly owned subsidiary of BioGenex, is pleased…
Rapid Therapeutic Science Laboratories Updates Patents
DALLAS, Dec. 13, 2022 (GLOBE NEWSWIRE) — Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic”…
Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA)
— Patents support Gritstone’s pioneering work in the application of next-generation samRNA vaccine technology in…
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
FDA approvals for both ASCENIV and BIVIGAM provide for room temperature (25°C) storage conditions for…
AEON Biopharma to Become Publicly Listed via Merger with Priveterra Acquisition Corp.; Accelerating Clinical Development of ABP-450 (prabotulinumtoxinA) Injection to Treat Debilitating Medical Conditions in Neurology
– Positive topline data from Phase 2 study of ABP-450 for cervical dystonia announced in…
Mobilicom Secures $100,000 Initial Order from New Tier-1 Customer
Mobilicom is now supplying 8 Tier-1 drone manufacturers worldwide, proving market adoption and indicating near-term…
Coastline Church Elevates Wi-Fi Connectivity, Reliability and Technology using Tellabs FlexAir with Optical LAN
Tellabs FlexAir™ Wi-Fi powered by Optical LAN, helps Coastline Church overcome modern wireless challenges with…
RTI to Exhibit and Showcase Connext Drive, the Connectivity Framework Enabling Software-Defined Vehicles, at CES 2023
RTI Automotive Experts to Demo Vehicle Technology & Address the Main Challenges in Developing Next-Generation…
Nubeva Announces Another Successful Ransomware Decryption
Nubeva’s Ransomware Reversal Solution successfully decrypts Black Basta attack on customer SAN JOSE, Calif., Dec….